Skip to content
healthcare.dev

Dalfampridine

NDC 0591-2533, Dalfampridine, tablet, film coated, extended release, from Actavis Pharma, Inc..

Product NDC
0591-2533
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206836
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2533 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALFAMPRIDINE10 mg/1

Pharmacologic classes

Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]

Package NDCNDC-11Package
0591-2533-600059125336060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-2533-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed826777-b8c4-4d35-aa64-a4c28452baa8
  • NADAC price for package 00591253360

    GET /v1/drugs/nadac/00591253360

Use it

Look up 0591-2533 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2533 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.